IP Library Assignment 026006/0375
Patent Assignment
Reel/Frame 026006/0375

Assignment of Assignor's Interest

Recorded: 2011-03-23 Pages: 4
Assignors
WARD, KEITH W.
Executed: 2011-03-10
ZHANG, JINZHONG
Executed: 2011-03-08
JONASSE, MATTHEW S.
Executed: 2011-03-10
Assignee
BAUSCH & LOMB INCORPORATED
ONE BAUSCH & LOMB PLACE, ROCHESTER, NEW YORK, 14604
Covered Property (1)
Compositions and Methods for Modulating Endophthalmitis Using Fluoroquinolones
Application: 13/038,805 →
Publication: US 2011/0166126
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →
Release of Security Interest Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
Security Agreement Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
Notice of Succession of Agency Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Release of Security Interest Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →